Generic Drugs – A Prescription Review With IMS Report
The IMS Institute was founded early in 2011 to beef up the collaboration of global healthcare and “in tandem with government agencies, academic institutions, industry of life sciences and payers to work together to create a research program dedicated to address the current challenges of healthcare”. The IMS report shows the continuation of a recent economy are moving towards generic drugs over brand names, also 4 billion prescriptions were written
